Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Elimination of Mother-to-Child HIV Transmission (EMCT) in the United States

Image of a pregnant woman

In collaboration with national experts and federal partners, the Centers for Disease Control and Prevention (CDC) has developed a new framework directed at the goal of eliminating mother-to-child (perinatal) HIV transmission (EMCT) in the United States. The framework is illustrated in Figure 1 [the numbers in superscript below refer to the corresponding numbered activities in the figure] and differs from the previous approach to PMTCT in its consistent use of public health personnel to 1) assure that HIV care includes comprehensive reproductive health, family planning services and preconception care and that women of childbearing age are HIV tested according to CDC recommendations1; and 2) conduct comprehensive, real-time case finding2 of all HIV-infected pregnant women and their exposed infants. These two large tasks are conducted under the concept of Perinatal HIV Services Coordination (PHSC). PHSC in each state (or jurisdiction) could assure comprehensive, real-time case finding. It may be helpful to have these functions combined with other related activities, such as the prevention of other perinatally acquired infections. With the financial realities facing all levels of government, and the fact that most HIV-infected pregnant women are, in fact, in care, it will not be possible—and may not be necessary—for PHSC to actively monitor each woman, once it has been determined that the woman is in care. On the other hand, for those women recognized as not in care, finding cases in real time would enable the conduct and coordination of the following components of the EMCT framework:

  • Comprehensive Care (facilitation of comprehensive clinical and psychosocial HIV services for women and infants3;)
  • Case Review and Community Action (FIMR-HIV) to identify and address missed prevention opportunities and local systems issues through continuous quality improvement4;
  • Research and long-term monitoring to develop and ensure safe and efficacious PMCT interventions5; and Data reporting for HIV surveillance and EMCT evaluation6.


Reproductive health, family planning services and preconception care

Increased identification of HIV infection prior to pregnancy, and maintenance of more women in care would result in more opportunities to optimize HIV-infected women’s health prior to and between pregnancies, particularly with new guidelines recommending early antiretroviral (ARV) treatment. Proper attention to women’s HIV care inclusive of reproductive health and family planning will support women prevent unintended pregnancy.

Comprehensive real-time case finding

A “case” is a pregnancy in an HIV-infected woman. Case-finding requires both universal HIV testing of pregnant women and a mechanism for detecting pregnancy among women with diagnosed HIV infection and is distinct from traditional HIV surveillance because cases must be identified in real time.

Comprehensive Care

Clinical management for HIV-infected pregnant women and their infants is credited with much of the documented reduction in MCT. Local expertise in clinical care has been nurtured by the support for clinical activities provided by the Health Resources and Services Administration (HRSA), under the Ryan White HIV/AIDS Program. Assuring linkages to these clinical providers is a key function of the PHSC. Under the financial restraints of recent years, jurisdictions will need to determine the degree of their involvement with individual HIV-infected pregnant women. Recent national health-care reform may enhance EMCT through reimbursement for preventive care and by facilitating access to care.

Because MCT is frequently the result of failures of local health systems, CDC has worked with partners to develop a community-based, continuous quality improvement methodology. This methodology is modeled after the HRSA-funded Fetal-Infant Mortality Review (FIMR) program. CDC funds the FIMR-HIV Prevention Methodology (FHPM) National Resource Center (www.fimrhiv.org) to support scale-up of this methodology in new sites such as health departments funded through CDC’s HIV Prevention cooperative agreements. With consent, FHPM summarizes the experience from the mother’s perspective through an interview and medical records abstraction. This de-identified information is presented to a multidisciplinary case review team to assess missed opportunities related to MCT and to develop recommendations for local system improvements. These recommendations are presented to community action teams of locally recognized persons who are in a position to implement the suggested system improvements. Cases of MCT occur in diverse and ever-changing environments, so utilizing a proven methodology to assess and improve local systems is particularly important. Such systems improvements could also affect other perinatal infections (e.g., hepatitis B infection and syphilis) and maternal and child health services overall.

Research and long-term monitoring

The prevention regimens used are evolving and expose thousands of children to antiretroviral medications every year. Research to monitor the long-term safety and efficacy of interventions for both women and ARV-exposed children needs a long-term plan and sustained action.

Top of Page

Data reporting

Accurate data reporting is necessary to direct the activities described above, and should include surveillance of all infants born to HIV-infected women (“perinatal HIV exposure”). Without exposure reporting, it is challenging if not impossible to understand progress or lack thereof toward the goal of EMCT.

This framework describes how health care and public health systems may interact to eliminate mother-to-child HIV transmission in the United States. Considering the multifaceted approach of the framework, as well as the current strain on resources, reaching elimination will require coordination and active collaboration across multiple agencies at the national, state and local level. However, preventing perinatal transmission at the individual level includes a series of clinical interventions. These interventions are outlined in the Perinatal HIV Prevention Cascade (Figure 2) adapted from the Institute of Medicine 1998 report, Reducing the odds: Preventing perinatal transmission of HIV in the United States.

Figure 1 is the Framework to Eliminate Mother-to-Child HIV Transmission (EMCT)
This figure illustrates the 6 key domains of the EMCT Framework. Domains 1 and 2 are the foundation for the other 4 domains; furthermore, all of the domains are meant to be interactive. The domains are: 
1. Reproductive health and family planning services, preconception care, and universal HIV testing
2. Comprehensive real-time case finding
3. Facilitation of clinical and psychosocial services for women and infants
4. Case review and community action (FIMR/HIV)
5. Research and long-term monitoring
6. Data reporting

Figure 1 - Framework to Eliminate Mother-to-Child HIV Transmission (EMCT)


Figure 2 shows the perinatal prevention cascade for HIV infection, which are the missed opportunities that can lead to a child being infected with HIV are listed in a column on the left and the corresponding prevention opportunities are listed in a column on the right.  To optimize a woman’s health and to prevent perinatal transmission, all of the prevention opportunities listed on the right need to be in place and available to all women living with HIV infection.  The missed opportunities (which will be referred to as MO) and the prevention opportunities (which will be referred to as PO) are:
MO: HIV-infected woman (HIV status may be either known or unknown)—PO: Primary HIV prevention for women and girls
MO: No preconception care—PO: Adequate preconception care and family planning services
MO: Become pregnant—PO: Adequate preconception care and family planning services
MO: No prenatal care—PO: Accessible, affordable and welcoming prenatal care
MO: No prenatal HIV Test—PO: Universal prenatal HIV testing (routine, opt-out)
MO: Inadequate ARV prophylaxis—PO: Providing ARV prophylaxis to all eligible 
MO: No cesarean delivery—PO: Utilize cesarean delivery if maternal viral load is >1000 copies/ml
MO: Breastfed infant—PO: Education and support on avoidance of breastfeeding 
MO: Child infected despite treatment: Comprehensive services for mother and infant

Figure 2 - Perinatal HIV Prevention Cascade

Source Report: Institute of Medicine, 1998

Top of Page


1 Reproductive health and family planning services, preconception care, and universal HIV testing are essential components of EMCT and facilitate 2 comprehensive real-time case finding of all HIV-infected pregnant women. Real-time case finding enables: 3 comprehensive clinical care and social services for women and infants; 4 detailed review of select cases to identify and address missed prevention opportunities and local systems issues through continuous quality improvement; 5 research and long-term follow-up to develop and ensure safe, efficacious interventions for EMCT; 6 thorough data reporting for HIV surveillance and EMCT evaluation.

 

Get Tested


Find an HIV testing site near you.

Search location, such as: "Atlanta, GA", or "30033".

For more information, please visit gettested.cdc.gov

Please contact GETTESTED-Webmaster@cdc.gov with any comments, suggestions, or concerns.


Syndicate This Content Podcast button Tell us what you think button CDC-INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO